microemulsion formulation of cyclosporin a (csa) in autoimmune hepatitis (aih)

Population pharmacokinetic analysis of the microemulsion formulation of cyclosporin A (Neoral®) in renal transplant patients

Manifestation of connective tissue diseases (CTD) in pediatrics patients with autoimmune hepatitis (AIH)

Background Autoimmune hepatitis (AIH) is a progressive inflammatory fribrosing disease of the liver of unknown etiology, which in its normal progress leads to cirrhosis. It is characterized by the increase in aminotranferases and hypergammaglobulinemia, and the presence of nonorgan and specific liver autoantibodies in serum, which allow for its classification. Two subtypes are differentiated: T...

Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation.

A 53-year-old man with Behçet disease was treated with conventional cyclosporin A (CyA), because of refractory bilateral uveitis. Immediately following the conversion from conventional CyA to a microemulsion formulation, he presented with neurological complications. The neurological findings, pleocytosis of the cerebrospinal fluid (CSF) and brainstem lesions revealed by brain magnetic resonance...

Autoimmune hepatitis

Autoimmune hepatitis is (AIH) is a chronic hepatitis that occurs in children and adults of all ages. It is characterized by immunologic and autoimmune features, including circulating auto antibodies and high serum globulin concentrations. It was first described in the 1950s by term of chronic active hepatitis. It has 2 types with different auto antibodies. Diagnosis is based upon serologic and ...

Childhood Autoimmune Hepatitis in Bahrain: a Tertiary Center Experience

Background: Autoimmune hepatitis (AIH) in childhood has variable modes of presentation, and the disease should be suspected and excluded in all children presenting with symptoms and signs of prolonged or severe acute liver disease. In AIH, the liver biopsy histopathology shows inflammation in addition to presence of serum autoimmune antibodies and increased levels of immunoglobulin G (IgG). Ob...

Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996.